Distribution of hantavirus serotypes Hantaan and Seoul causing hemorrhagic fever with renal syndrome and identification by hemagglutination inhibition assay.
An epidemiologic evaluation of patients with hemorrhagic fever with renal syndrome from different locations in the People's Republic of China was conducted to define the prevalence of two Hantavirus serotypes, Seoul (SEO) and Hantaan (HTN). Serum specimens were collected between 5 and 14 days after the onset of illness and were tested for antibodies by both hemagglutination inhibition (HI) and plaque reduction neutralization (PRN). By the HI test, the geometric mean titer (GMT) of antibodies to SEO in the sera from individuals from Kaifeng City of Henan Province was five times higher than that to HTN. In contrast, by the HI test, the sera from individuals from Jiande County of Zhejiang Province had a GMT of antibodies to HTN that was seven times higher than that to SEO. In the sera from individuals from Shanghai, only a twofold difference was observed in HI antibody titers to the two hemagglutinins by the HI test, with that to HTN being higher than that to SEO. By the PRN test, the GMT ratios of antibody between HTN and SEO strains from individuals in Kaifeng, Jiande, and Shanghai were found to be 1:13, 14:1, and 2:1 respectively. A close correlation (r = 0.8219) and concordance rate (78.3%) were observed between the PRN and HI tests for the identification of the serotypes of individual cases of hemorrhagic fever with renal syndrome. The hantavirus serotypes from individuals in Kaifeng and Jiande were identified as predominantly SEO and HTN, respectively, and those from individuals in Shanghai had an indeterminant serotype defined by these two techniques. The HI test appears to be a simple and reliable way of determining the predominant hantavirus that causes HFRS in a given geographic area.
Department of Epidemiology, School of Public Health, Shanghai Medical University, People's Republic of China.
Y W
YW
Tang
Y L
YL
Li
K L
KL
Ye
Z Y
ZY
Xu
S L
SL
Ruo
S P
SP
Fisher-Hoch
J B
JB
McCormick
D000914:Antibodies, Viral / Q000097:blood; D002681:China / Q000453:epidemiology; D005069:Evaluation Studies as Topic; D006476:Orthohantavirus / Q000145:classification* / Q000276:immunology / Q000302:isolation & purification; D006385:Hemagglutination Inhibition Tests; D006480:Hemorrhagic Fever with Renal Syndrome / Q000453:epidemiology / Q000276:immunology / Q000382:microbiology*; D006801:Humans; D009500:Neutralization Tests; D016036:Seroepidemiologic Studies; D012703:Serotyping
D000914:Antibodies, Viral